Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...

For those with inflammatory bowel diseases like ulcerative colitis (UC), which includes symptoms like diarrhea, rectal ...

Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...

Arthritis is the most common nonintestinal complication for people with ulcerative colitis (UC). These tips can help stave it ...

New long-term data from Eli Lilly and Company show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease clearance through ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

In children hospitalised with acute severe ulcerative colitis on intravenous corticosteroids, intestinal ultrasound (IUS) parameters such as colonic wall thickness (CWT) were associated with ...

Researchers have used machine learning to identify a new antimicrobial peptide that reduces inflammation, restores gut barrier function and reshapes the microbiome in ulcerative colitis. Ulcerative ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal pain and diarrhea. Although current treatments, including 5-aminosalicylic ...

Imagine you and your gastroenterologist have discussed a new ulcerative colitis (UC) treatment plan that promises to reduce your symptoms and the stress that comes with them. Then, when you go to ...

The MarketWatch News Department was not involved in the creation of this content. Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and ...